We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$400K
Cap. Flow
-$5.62M
Cap. Flow %
-2.74%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
5
Closed
–

Top Buys

Rank Stock Value
1
CELL
PhenomeX Inc. Common Stock
CELL
+$39.3M

Top Sells

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$14.6M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$14.2M
3
CRL icon
Charles River Laboratories
CRL
+$8.31M
4
BLFS icon
BioLife Solutions
BLFS
+$6.67M
5
CTLT
CATALENT, INC.
CTLT
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.23B
$47.1M 22.92%
576,768
-181,571
-24% -$14.6M
CRL icon
2
Charles River Laboratories
CRL
$11B
$45.6M 22.18%
157,241
-29,897
-16% -$8.31M
CTLT
3
DELISTED
CATALENT, INC.
CTLT
$43.7M 21.27%
414,891
-10,109
-2% -$1.13M
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.05B
$29.1M 14.19%
51,023
-23,977
-32% -$14.2M
CELL
5
DELISTED
PhenomeX Inc. Common Stock
CELL
$29M 14.1%
+576,767
New +$39.3M
BLFS icon
6
BioLife Solutions
BLFS
$1.48B
$11M 5.34%
304,493
-168,607
-36% -$6.67M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Tower House Partners held 6 positions worth $205M, up 0.2% from $205M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners's Q1 2021 filing shows 1 new and 5 reduced positions. Its largest new stake was PhenomeX Inc. Common Stock: 576,767 shares worth $29M. The largest sale was Azenta, an estimated $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tower House Partners's largest Q1 2021 buy was PhenomeX Inc. Common Stock: 576,767 shares worth $29M.
  • Tower House Partners's biggest Q1 2021 reduction was Azenta, cutting an estimated $14.6M.
  • Tower House Partners's ten largest holdings make up 100% of its $205M portfolio in Q1 2021.
  • Tower House Partners opened 1 new position and closed 0 in Q1 2021.
  • Tower House Partners's portfolio value rose 0.2% quarter-over-quarter to $205M.

Based on Tower House Partners's 13F filing for Q1 2021, filed 17 May 2021.